600535:SHA
Tasly Pharmaceutical Group Co Ltd
CNÂ¥14,01
arrow_downward
-0,21%(-0,030) 1 HR
15 Okt, 11.29.48 GMT+8 · CNY
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk 600535...
Pembukaan
CNÂ¥14,04
Tinggi
CNÂ¥14,31
Rendah
CNÂ¥13,93
Kapitalisasi pasar
20,87Â M
Volume rata-rata
11,39Â jt
Volume
10,53Â jt
Dividen
2,43%
Dividen per kuartal
CNÂ¥0,09
Tanggal tanpa dividen
29 Mei 2026
Rasio P/E
17,11
Harga tinggi dalam 52 minggu terakhir
CNÂ¥16,24
Harga rendah dalam 52 minggu terakhir
CNÂ¥12,90
EPS
CNÂ¥0,82
Saham beredar
1,51Â M
Jumlah karyawan
11Â rb
Pembukaan
CNÂ¥14,04
Tinggi
CNÂ¥14,31
Rendah
CNÂ¥13,93
Kapitalisasi pasar
20,87Â M
Volume rata-rata
11,39Â jt
Volume
10,53Â jt
Dividen
2,43%
Dividen per kuartal
CNÂ¥0,09
Tanggal tanpa dividen
29 Mei 2026
Rasio P/E
17,11
Harga tinggi dalam 52 minggu terakhir
CNÂ¥16,24
Harga rendah dalam 52 minggu terakhir
CNÂ¥12,90
EPS
CNÂ¥0,82
Saham beredar
1,51Â M
Jumlah karyawan
11Â rb
Saham terkait
Artikel berita
Dari sumber web dan partner berita
Ajaib
·
38 menit yang lalu
Wall Street Hari Ini: Inflasi AS Naik, Nasdaq dan S&P 500 Terkoreksi
Pluang
·
17 jam yang lalu
Opsi S&P 500 kuasai volume $640 juta di Hyperca...
BeInCrypto
·
3 jam yang lalu
S&P 500 Masuk ke Periode Musiman Terkuat
Pluang
·
9 jam yang lalu
Citi target S&P 500 di 8.100 jika sektor sensit...
Profil
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Tentang Tasly Pharmaceutical Group Co Ltd